The Board of Directors of Ilsung Pharmaceuticals Co. Ltd. (KOSE:A003120) authorized a share repurchase program on April 15, 2013. Under the program, the company will repurchase up to 50,000 shares for an estimated cost of KRW 3.91 billion.

Repurchases will be made from the stock exchange. Repurchases will commence on April 16, 2013 and will continue until July 15, 2013. As of April 14, 2013, the company has 1,291,365 shares in treasury.

Samsung Securities Co.,Ltd., Woori Investment & Securities Co.,Ltd., Daewoo Securities Co.,Ltd. and SINHAN INVESTMENT CORP. acted as brokers to the company.